InSysBio announces its participation in the PAGE Meeting 2026 which is to be held from June 2-5, 2026 in Dubrovnik, Croatia. InSysBio team is going to present its QSP modeling services & software to optimize drug development at Booth #22 and posters, namely:
Poster Session II, Wednesday, June 3, 15:20 PM–16:50 PM:
Software Demonstration:
Check out our posters and Booth #22!
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio's cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | February 2025 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
| |||||
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
|
17
|
18
|
19
1.
19 Feb 2025 14:42
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
The new article “Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell Malignancies” has been recently published. The work was supported by BeiGene.
|
20
|
21
|
22
|
23
|
|
24
|
25
|
26
|
27
|
28
| ||
Thank you for your message! We will get back to you shortly.
